Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Prion|March 31, 2012
Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic miceEliezer Masliah, Edward Rockenstein, Chandra Inglis, et al.
Plos One|May 12, 2015
The temporal expression pattern of alpha-synuclein modulates olfactory neurogenesis in transgenic miceSebastian R Schreglmann, Martin Regensburger, Edward Rockenstein, et al.
Journal of Neurovirology|December 22, 2007
Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegenerationShahid Salaria, Haleh Badkoobehi, Edward Rockenstein, et al.
Plos One|April 30, 2015
Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's diseaseNazneen N Dewji, S Jonathan Singer, Eliezer Masliah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 18, 2012
Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBDBrian Spencer, Sarah Michael, Jay Shen, et al.
Plos One|May 21, 2010
In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobilityVivek K Unni, Tamily A Weissman, Edward Rockenstein, et al.
Scientific Reports|November 3, 2018
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's diseaseDiana L Price, Maya A Koike, Asma Khan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 17, 2010
Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesisLeslie Crews, Anthony Adame, Christina Patrick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2025
Retraction Notice to: Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBDBrian Spencer, Sarah Michael, Jay Shen, et al.
Neuroreport|August 13, 2008
Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophyKiren Ubhi, Edward Rockenstein, Michael Mante, et al.
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Prion|March 31, 2012
Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic miceEliezer Masliah, Edward Rockenstein, Chandra Inglis, et al.
Plos One|May 12, 2015
The temporal expression pattern of alpha-synuclein modulates olfactory neurogenesis in transgenic miceSebastian R Schreglmann, Martin Regensburger, Edward Rockenstein, et al.
Journal of Neurovirology|December 22, 2007
Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegenerationShahid Salaria, Haleh Badkoobehi, Edward Rockenstein, et al.
Plos One|April 30, 2015
Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's diseaseNazneen N Dewji, S Jonathan Singer, Eliezer Masliah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 18, 2012
Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBDBrian Spencer, Sarah Michael, Jay Shen, et al.
Plos One|May 21, 2010
In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobilityVivek K Unni, Tamily A Weissman, Edward Rockenstein, et al.
Scientific Reports|November 3, 2018
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's diseaseDiana L Price, Maya A Koike, Asma Khan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 17, 2010
Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesisLeslie Crews, Anthony Adame, Christina Patrick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2025
Retraction Notice to: Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBDBrian Spencer, Sarah Michael, Jay Shen, et al.
Neuroreport|August 13, 2008
Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophyKiren Ubhi, Edward Rockenstein, Michael Mante, et al.
Pageof 20